The Mushroom Molecule That May Rewrite Aging: Ergothioneine Emerges as a Multi-Target Geroprotector

News
#1

ErgothionineResearch
ErgothionineResearch1920×1072 311 KB

Hidden in a plate of shiitake mushrooms is a molecule that may be quietly keeping your cells alive. Ergothioneine (ET) — a sulfur-rich amino acid first isolated from ergot fungus in 1909 — has spent over a century in relative obscurity. That may be about to change.

A sweeping new systematic review published in Ageing Research Reviews synthesizes 20 years of evidence (2005–2025) and makes a forceful case: ET is not merely an antioxidant curiosity but a plausible geroprotector — a compound capable of targeting multiple molecular mechanisms that drive biological aging simultaneously.

The big idea begins with a specialized protein called OCTN1, encoded by the gene SLC22A4. Unlike generic antioxidants that spray-and-pray across tissues, OCTN1 acts as a precision delivery system, ferrying ET specifically into the cells and organs most vulnerable to oxidative damage: the brain, liver, kidneys, eyes, and bone marrow. This selective accumulation is not passive — it is active, energy-dependent, and regulated. Critically, blood levels of ET peak in adolescence at approximately 3.7 mg/100 mL and then decline progressively with age. Lower ET levels have been independently correlated with frailty, mild cognitive impairment, Parkinson’s disease, and all-cause mortality in large cohort studies. This age-related depletion pattern is one reason Nobel laureate biochemist Bruce Ames proposed the “longevity vitamin” hypothesis — the idea that ET is a micronutrient we chronically under-consume, and whose deficit accelerates aging.

The review maps ET’s effects onto the canonical “Hallmarks of Aging” framework. Its actions span telomere preservation (by protecting guanine-rich telomeric DNA from oxidative attack and upregulating SIRT1/SIRT6), mitochondrial quality control (restoring mitophagic flux via PINK1/Parkin pathways), suppression of the pro-inflammatory Senescence-Associated Secretory Phenotype (SASP) via NF-kB inhibition, and modulation of the mTORC1-S6K1 nutrient-sensing axis.

But the most intellectually disruptive finding reviewed here concerns a newly characterized mechanism: ET does not merely neutralize reactive oxygen species — it actively reprograms cellular energy metabolism. Recent data from two independent 2025 studies (Petrovic et al. and Sprenger et al.) demonstrate that intracellular ET binds and activates key sulfur-trafficking enzymes (MPST and CSE), triggering localized hydrogen sulfide (H2S) production. This H2S then persulfidates cytosolic glycerol-3-phosphate dehydrogenase (cGPDH), directly enhancing electron transport chain efficiency and maximizing ATP output. This elevates ET from “defensive scavenger” to “proactive metabolic optimizer” — a mechanistic upgrade with profound implications.

In male mice, ET supplementation at 4–5 mg/kg/day extended median lifespan by 16% and mean lifespan by 21% (Katsube et al., 2024). In Drosophila, lifespan extension was demonstrated across multiple dose ranges.

The honest caveat: human RCT data remains thin. A large cohort study of 3,236 participants over 21 years shows compelling observational links between plasma ET and reduced cardiovascular mortality, but causality is not established. Phase 1 and Phase 2 human trials confirm safety up to 25 mg/day with no adverse signals, but adequately powered, long-term efficacy trials with hard clinical endpoints do not yet exist.

Actionable Insights

The most immediate practical signal from this review is dietary: eat mushrooms. Oyster, shiitake, and king oyster mushrooms contain 1–7 mg ET per gram dry weight, making them by far the richest accessible source. Regular mushroom consumption is the primary way to counter the age-related decline in blood ET levels.

Second, genetic context matters. If you carry the SLC22A4 L503F (C1672T) variant, standard dietary intake may be insufficient to raise tissue ET to protective levels — and counterintuitively, this variant may increase autoimmune risk in inflammatory contexts. Genetic testing for SLC22A4/SLC22A15 polymorphisms could eventually guide individualized ET protocols.

Third, ET operates as an “on-demand” protector: supplementation in healthy, low-stress individuals produces minimal biomarker changes. The benefit signal strengthens under oxidative load — which means individuals with metabolic syndrome, cardiovascular disease, neurodegenerative risk, CKD, or those undergoing hemodialysis (where ET is depleted by 88%) represent the clearest candidates for supplementation trials.

Pulsed Dose: ET exhibits non-linear pharmacokinetics, high systemic accumulation, active renal reabsorption, and an exceptionally long human half-life of approximately 30 days. Continuous daily high-dose supplementation risks saturating the limited capacity of the OCTN1 transporter and may impede the absorption of essential physiological cations or co-administered drugs like metformin. Intermittent pulse dosing is theoretically superior to avoid transport bottlenecks.

Mandate Baseline Genetic and Microbiome Screening: Supplemental ET is highly context-dependent and presents an unexpected biological “Achilles’ heel”. Certain anaerobic gut bacteria express ET hydrolases that cleave ET into trimethylamine (TMA), which the liver converts into trimethylamine-N-oxide (TMAO)—a notorious pro-atherogenic metabolite linked to accelerated vascular aging and cardiovascular disease. Individuals must profile their gut microbiome and verify their SLC22A4 genotype (specifically checking for the L503F variant, which dramatically alters baseline transport efficiency) before initiating heavy, unmonitored supplementation protocols.

The current clinically validated dosage range is 5–25 mg/day, with safety confirmed up to 16 weeks in elderly subjects.

Source:

Related Reading:

5 Likes
#2

To practically mitigate the vascular “Achilles’ heel” of Ergothioneine (ET) supplementation—specifically the risk of converting a potential geroprotector into the pro-atherogenic cardiovascular toxin trimethylamine-N-oxide (TMAO)—microbiome screening must evaluate two primary physiological axes: Direct Bacterial Cleavage into Trimethylamine (TMA) and Competitive Hijacking by Pathogens.

1. The TMA/TMAO Metabolic Conversion Profile

Evaluating your system’s propensity for turning amine donors into vascular toxins requires auditing specific bacterial degradation enzymes and overall metabolic capacity.

  • Ergothioneine Hydrolase / Ergothionase Activity: You should prioritize evaluating the presence and transcriptomic abundance of anaerobic gut bacteria harboring functional ET hydrolase (ergothionase) enzymes. Certain anaerobic species actively utilize this enzymatic pathway to cleave the structural imidazole ring of ET, liberating volatile TMA gas directly into portal circulation.
  • Core Amine-Lyase Genetic Machinery (CutC/D and CntA/B): Because direct ergothionase screening is not yet universally isolated on standard commercial functional stool tests, you must look at the surrogate genetic machinery regulating parallel TMA pathways. High expression of these genes signals an internal ecosystem highly efficient at carnitine, choline, and overall amine degradation:
    • CutC (Choline TMA-lyase) & CutD (Glycyl Radical Enzyme Activase): Regulates radical-driven cleavage of quaternary amines.
    • CntA (Rieske-type oxygenase) & CntB (Reductase): Drives the carnitine-to-TMA conversion line.

Clinical Risk Stratification: If metatranscriptomic data reveals high baseline copy numbers of CutC/Dor CntA/B, your microflora is fundamentally primed for rapid amine cleavage. Supplementing with heavy exogenous ET in this state risks accelerating endothelial dysfunction, renal fibrosis, and vascular aging via sudden spikes in downstream hepatic TMAO conversion.

  • Taxonomical Overrepresented Overgrowths: Audit your metagenomic sequencing for heavy colonial overgrowths of specific anaerobic groups notorious for executing high-efficiency amine transformations. This includes members of the Firmicutes phylum (particularly within the Clostridiaceae and Lachnospiraceae families) and select opportunistic Enterobacteriaceae.

2. Opportunistic Pathogen Abundance

A critical knowledge gap in broad-spectrum longevity medicine is the “dark side” of ET accumulation within highly infectious microenvironments. Multiple host-associated microbial pathogens lack the internal biochemical machinery to synthesize low-molecular-weight thiols to serve as their own cellular redox buffers. To survive host immune destruction, they pull host-derived ET out of the mucosal lining to protect themselves.

  • Helicobacter pylori (Gastric Mucosal Hijacking): H. pylori utilizes a highly specialized, high-affinity ATP-binding cassette transporter called EgtUV to aggressively hoard host environment ET. It uses your ingested ET to successfully neutralize the intracellular reactive oxygen species (ROS) deployed by human neutrophils during an immune response.Actionable Strategy: Blindly supplementing with ET when H. pylori is present effectively feeds the pathogen its prime survival shield, extending its virulence window and compounding long-term gastric cancer risks. Ensure zero active colonizations via a fecal antigen, urea breath test, or comprehensive GI-MAP sequencing.
  • Streptococcus pneumoniae and Listeria monocytogenes: Both pathogens utilize homologous EgtU import complexes to actively capture host ET for oxidative stress defense. Heavy baseline pathogen loading in the respiratory or gastrointestinal tract dictates a strict contraindication for high-dose prophylactic ET protocols until resolving structural dysbiosis.

3. Complementary Host Diagnostics & Stratification

Metagenomic stool analytics should always be paired with direct physiological markers to confirm total system clearance and transport capacity:

  • Baseline Circulating Plasma TMAO Test: Quantify baseline fasting plasma TMAO via liquid chromatography-tandem mass spectrometry (LC-MS/MS). If baseline values reside in upper-tier clinical risk zones, ET supplementation must be entirely avoided or strictly substituted with whole-food mushroom consumption, which alters kinetic absorption patterns and limits immediate transporter saturation.
  • Transporter Genotyping (SLC22A4): Map single nucleotide polymorphisms (SNPs) dictating your baseline absorption kinetics. Carriers of the L503F (C1672T) variant possess higher baseline absorption and elevated tissue ET concentrations but show an intricate, bidirectional link to autoimmune susceptibility (e.g., Crohn’s disease and rheumatoid arthritis). In these individuals, high local accumulation under continuous microbial challenge can flip ET from a passive cytoprotectant into a proactive pro-inflammatory driver that triggers Th17 immune skewing.

Current Scholarly Debates & Missing Data

While preclinical data clearly validates that intestinal microbes can cleave ET into pro-atherogenic precursors, a prominent knowledge gap remains regarding the precise diet-microbe-host axis dynamics in long-term human cohorts.

There is an active debate over whether localized tissue accumulation of ET in inflamed environments represents a failed, exhausted compensatory defense mechanism or an active pathogenic driver of local tissue injury. Systematic testing with stable isotope tracing is urgently needed to fully map the net lifestyle outcomes of ET exposure within highly variable human enterotypes. For a detailed systemic analysis of these metabolic frameworks, consult the comprehensive scoping review published in Ageing Research Reviews.

1 Like
#3

Recommended Plasma TMAO Testing Timeline After Ergothioneine Dosing

Because the specific interaction between ergothioneine (ET) and the human gut microbiome remains an emerging frontier, there is currently no universally standardized, clinically validated diagnostic timeline for an “ET-to-TMAO dynamic challenge test.” However, by synthesizing the known pharmacokinetics of ET alongside established clinical protocols for parallel quaternary amine challenges (such as choline and carnitine loading), a rational testing framework can be engineered.

1. The Post-Challenge Peak Window (Acute Conversion Capacity)

To catch the active microbial cleavage and subsequent hepatic oxidation of a specific dose, plasma should be drawn 6 to 8 hours post-ingestion of your ET supplement.

  • Gastrointestinal Transit and Processing: Ingested ET must escape complete upper small intestine absorption by the high-affinity OCTN1 transporter to interact with anaerobic microbes in the distal gut. Preclinical tracer data demonstrates that oral ET reaches peak concentrations in the small intestine around 4 hours post-dose.
  • TMA to TMAO Kinetics: Once anaerobic bacteria harboring ET hydrolases cleave the molecule into volatile trimethylamine (TMA), the gas is rapidly absorbed via portal circulation. The hepatic flavin-containing monooxygenase 3 (FMO3) enzyme then oxidizes TMA into TMAO. Based on standard oral choline or carnitine loading tests, this total pathway cascade peaks in the blood between 6 and 8 hours before gradual renal clearance begins.

2. The Fasting Steady-State Test (Chronic Accumulation)

To determine whether your long-term supplement regimen is systematically driving up your baseline cardiovascular risk, you should test fasting plasma TMAO (minimum 12-hour fast) at least 2 to 4 weeks into a consistent dosing protocol.

  • Kinetic Rationale: Human single-dose and steady-state kinetics demonstrate that ET concentrations build progressively over time, reaching a stable systemic plateau after approximately 4 weeks of daily intake.
  • Sustained Half-Life Impact: Because ET possesses an exceptionally long systemic half-life of roughly 30 daysdue to aggressive renal reabsorption, testing a standard fasting baseline after a month of exposure provides a highly accurate look at your sustained, chronic exposure to downstream microbiota-generated toxins.

Practical Summary Protocol

  • Step 1 (True Baseline): Establish a true baseline by drawing fasting plasma TMAO before initiating any ET supplementation.
  • Step 2 (The Acute Audit): Ingest your target heavy supplement dose. Draw blood 6 to 8 hours laterto audit whether your specific gut enterotype is aggressively converting the parent compound into TMA.
  • Step 3 (The Steady-State Audit): If you proceed with chronic supplementation, re-verify your fasting plasma TMAO 4 weeks later to ensure you have not pushed your steady-state vascular environment into a pro-atherogenic danger zone.
2 Likes
#4

Given its 30-day half-life, it may be safer but still effective to dose once a month. None of the above suggests that a high steady-state concentration is ideal. Archeologists speculate that mushrooms were available to our foraging ancestors primarily during the wet season, a limitation that may be reflected in our biology.

https://rrcultivation.com/blogs/mn/exploring-the-role-of-mushrooms-throughout-history

1 Like
#5

My approach is 30mg/day for one month to reach saturation levels. Then one month break. I eat a fair amount of mushrooms in my diet. For TMAO concerns, a high intake of vegetables and very high levels of various forms of fiber are helpful, which you should be doing anyway. YMMV.

2 Likes
#6

I’m going to add a TMAO test to my bloodwork the next time I go in. Have you ever checked your TMAO levels?

One of the issues I’ve seen in the research that too much fiber (of certain types) can also cause high TMAO levels… see: Butyrate: The Microbiome's Anti-Aging "Kill Switch" for Senescent Cells - #131 by starspawn0

#7

I have never tested for TMAO. I supplement with various fiber types, though not resistant starches. There are two reasons I don’t supplement with RS - the practical one is that you are looking at large amounts, like 40g/day for certain effects (visceral fat), second, resistant starches have calories (2-3 per gram), so you might be hitting 100 calories a day (apart from the SCFA contribution, as I posted), and I do not wish to add more calories to my diet, trying to keep calories lowish; in this light RS are suboptimal in my book. This doesn’t mean RS impact on weight, but other processes by which calories are disposed of by RS metabolism, also dependent on the type of resistant starch R1, R2, R3, R4, R5 etc. It all gets rather complicated, and rather than jumping through hoops I prefer to stick to other fiber types, although of course I do get some RS through my diet, I just don’t supplement specifically with RS though I do with other fiber types. YMMV.

Synthesis and Functions of Resistant Starch

Resistant starch and energy balance: impact on weight loss and maintenance

1 Like
#8

i have been taking this for several years as one of the 10 supplements for longevity chosen by Bruce Ames, a brilliant biochemist.

1 Like
#9

Taking how (dosage, protocol etc)? It seems this might be an important factor and variable. Powerful molecules can be powerful in unintended ways.

1 Like
#10

my n1: A morning dose of approximately 10 grams of dried porcini mushrooms consistently reduces my afternoon brain fog and markedly attenuates my typical caffeine crash. I am highly caffeine‑sensitive due to reduced activity of the hepatic enzyme CYP1A2, the primary cytochrome P450 isoform responsible for caffeine metabolism. The ergothioneine in porcini appears to buffer the physiological stress that normally amplifies my caffeine intolerance, and it also seems to exert a stabilizing effect on some brain functions.

2 Likes
#11

Thought I’d check on the pricing for these… Top 10 lowest-cost sources for Dried Oyster, Shiitake, Porcini & King Oyster Mushrooms, packaged in weights of 450 grams to 2 kg. (From Claude Sonnet 4.6):

Top 10 Lowest-Cost Sources: Dried Oyster, Shiitake, Porcini & King Oyster Mushrooms

Research date: May 31, 2026 | Prices in USD | Sorted by lowest cost per 100g

Packaging note: The US market predominantly packages dried mushrooms in 1 lb (454g) increments, which falls within the 450g–2kg target range. Three entries (Ranks 2, 3, 7) are 5 lb (2,268g) bulk bags — these slightly exceed the 2kg upper limit and are marked with an asterisk. They are included because they represent the lowest per-100g costs available and are of direct value to bulk procurement.

Rank Product/Brand Name (Exact Title) Vendor Total Weight (Original / Grams) Total Price (USD) Cost Per 100g
1 Dried Oyster Mushrooms – 1 lb (16 oz) Forest Mushrooms 1 lb / 454g $20.00 $4.41
2 Whole Shiitake Mushrooms – 5 lb Bulk Bag * BulkFoods.com 5 lb / 2,268g $103.95 $4.58
3 King Oyster Mushrooms, Dried – 5 lb bag * Essential Spice 5 lb / 2,268g $105.03 $4.63
4 Whole Shiitake Mushrooms – 1 lb Zip Bag BulkFoods.com 1 lb / 454g $23.59 $5.19
5 Dried Shiitake Mushrooms, whole (bulk) – 1 lb Forest Mushrooms 1 lb / 454g $24.00 $5.29
6 Shiitake Mushrooms – 1 lb bag Mount Hope Wholesale 1 lb / 454g $28.30 $6.23
7 Sliced Porcini Mushrooms – 5 lb Bulk Bag * BulkFoods.com 5 lb / 2,268g $159.95 $7.06
8 Sliced Porcini Mushrooms – 1 lb Zip Bag BulkFoods.com 1 lb / 454g $34.49 $7.60
9 King Oyster Mushrooms, Dried – 1 lb bag Essential Spice 1 lb / 454g $35.22 $7.76
10 Dried Organic USA King Trumpet Mushrooms – 1 lb Forest Mushrooms 1 lb / 454g $45.00 $9.91

** 5 lb (2,268g) packages slightly exceed the 2kg upper limit. Included for procurement value; verify with vendor if packaging flexibility exists.*

Mushroom Type by Rank

  • Oyster: Ranks 1, 10-runner-up
  • Shiitake: Ranks 2, 4, 5, 6 — dominated by low per-100g costs; best overall value
  • King Oyster: Ranks 3, 9, 10
  • Porcini: Ranks 7, 8 — consistently the highest cost per 100g across all sources

Shipping Cost Summary

  • Forest Mushrooms: FREE on orders $75+; $5 on $50–$75 orders; $8 under $50. The 1 lb oyster ($20) and 1 lb shiitake ($24) each incur $8 shipping unless bundled to reach the $75 free-ship threshold.
  • BulkFoods.com: Flat $5 shipping (most states); FREE on orders $75+. All 5 lb bulk bags ($103–$159) qualify for free shipping.
  • Mount Hope Wholesale: FREE shipping on orders over $60 (continental US). The 1 lb shiitake ($28.30) requires additional items to qualify.
  • Essential Spice: FREE shipping on orders over $50. The 1 lb King Oyster ($35.22) does not meet the threshold alone; the 5 lb bag ($105.03) does.

Additional Notes

  • SpiceJungle listed competitive shiitake and porcini pricing ($36.96/lb and $73.26/lb respectively) but was confirmed out of stock on both as of May 31, 2026.
  • Forest Mushrooms’ dried oyster at $4.41/100g is the single lowest-cost per 100g among all individually packaged (sub-2kg) products across all four mushroom types.
  • King oyster mushrooms carry a significant premium over oyster and shiitake — even the best king oyster price ($4.63/100g in 5 lb bulk) equals the best shiitake bulk price.
#12

Follow on Gemini prompt to identify the commonality of the SLC22A4 genotype (specifically checking for the L503F variant, which dramatically alters baseline transport efficiency:

Are there scientific or clinical evidence on the commonality (what percent of the population) have the L503F variant of the SLC22A4 genotype?

Gemini Pro Response:

Extensive genomic profiling across global reference databases, including gnomAD and the 1000 Genomes Project, demonstrates that the L503F variant of the SLC22A4 gene (commercially mapped as single nucleotide polymorphism rs1050152, where the reference allele C mutates to the missense variant allele T) displays profound population-specific heterogeneity.

The presence of this functional variant—which alters the transport affinity of the organic cation/ergothioneine transporter OCTN1—varies from being highly prevalent to virtually non-existent depending on genetic ancestry.

Global Population Frequencies of rs1050152 (L503F)

The structural distribution of the risk allele (T) across distinct major ancestries outlines the exact commonality of the genotype:

Ancestry Group Minor Allele Frequency (MAF / % of Gene Pool) Calculated Total Carrier Frequency (Have ≥1 Copy)
European (Caucasian) ≈ 39.0% – 42.0% ≈ 63.0% – 66.0%
Ashkenazi Jewish ≈ 39.6% ≈ 63.5%
Latino / Admixed American ≈ 27.0% ≈ 46.7%
African / African-American ≈ 7.2% ≈ 13.9%
East Asian <0.1% (≈ 0.06%) <0.2%

Why Does This Matter?

The presence or absence of the L503F variant of the SLC22A4 gene (rs1050152) dictates the baseline absorption, tissue concentration, and homeostatic safety profile of ergothioneine (ET). This missense mutation fundamentally alters the kinetics of the organic cation transporter OCTN1, shifting it from a tightly regulated, stress-responsive gatekeeper into a hyper-efficient, constitutively active conduit.

The L503F Variant Profile (Genotype: CT or TT)

Individuals carrying at least one copy of the mutated T allele experience altered transport mechanics that present a dual-edged sword for longevity protocols:

  • Hyper-Efficient Baseline Absorption: The L503F mutation alters the structural confirmation of the OCTN1 transporter, significantly increasing its baseline transport efficiency and gastrointestinal absorption capacity. Consequently, carriers exhibit significantly higher baseline plasma and tissue ET concentrations compared to wild-type individuals under identical dietary conditions

The Supplementation Responsiveness Paradox: The literature highlights an important kinetic ceiling for carriers. While carriers have higher baseline tissue levels due to increased initial transport efficiency, they may prove less responsive to high-dose exogenous supplementation. Because their baseline cellular compartments are already highly saturated, administering standardized high doses yields diminished relative returns and increases the risk of sidetracking shared transport pathways for other essential cations.

Comparative Mechanics of Ergothioneine Processing

The behavioral differences between the two genetic profiles shape distinct metabolic pathways and clinical risks:

Pharmacokinetic Dimension Wild-Type (CC Genotype) L503F Variant (CT/TT Genotype)
Baseline Absorption Velocity Standard; regulated by immediate cellular demand and baseline affinity profiles. Significantly accelerated; baseline transport kinetics are constitutively elevated.
Steady-State Tissue Concentrations Lower; baseline tissue reserves remain modest until stress triggers active transport upregulation. Highly elevated; chronic accumulation results in systemic tissue saturation.
Immunological Risk Profile Low; minimal risk of ET acting as an auto-inflammatory or Th17-skewing catalyst. High; hyper-concentrations can paradoxically fuel sterile inflammation under chronic TLR activation.
Optimal Biohacking Dosing Strategy High Efficacy for Supplementation: Responds predictably to standard pulse or daily dosing (10–25 mg/day). Targeted Restriction: Focus primarily on a whole-food fungal matrix or low-dose pulse protocols (≤5–10 mg) to prevent over-saturation.

Summary for Longevity Protocols

Knowing your SLC22A4 status changes how you should approach ergothioneine. If you are wild-type (CC) , your body uses Ergothioneine as an elite, on-demand shield; you can safely utilize standard supplemental doses to maximize your systemic defenses during periods of high stress.

If you carry the L503F variant (CT or TT) , your body is already highly efficient at pulling Ergothioneine from your diet. Adding aggressive, high-dose supplements to an already saturated system offers little benefit and could backfire—potentially driving systemic inflammation if your gut microbiome or immune system is already compromised. For carriers, less is more: prioritize modest dietary intake from whole mushrooms and avoid excessive synthetic supplementation.

4 Likes
#13

Ergothioneine (EGT) in Mushrooms and Other Foods

Ergothioneine is a sulfur-containing amino acid derivative, sometimes called the “longevity vitamin.”

Critical measurement caveat: Ergothioneine values vary substantially across studies due to mushroom strain, growing substrate, geographic origin, and cultivation method. Fresh mushrooms are ~88–92% water, so 100g of dried mushroom represents roughly 800–1,000g of fresh weight — making dried values approximately 8–10x higher than fresh-weight values. The tables below use dry weight (DW) basis as requested (100g dried), sourced from peer-reviewed research (Tian et al. 2023, British Journal of Nutrition; ScienceDirect drying study 2023).

Part 1: Ergothioneine in 100g of Dried Mushrooms

Ranked: Oyster, Shiitake, Porcini & King Oyster

Rank Mushroom Type Ergothioneine per 100g Dried (mg) Notes
1 Oyster (Pleurotus ostreatus) ~200–220 mg Highest among the four in dry-weight peer-reviewed studies; retains well after hot-air drying
2 Shiitake (Lentinula edodes) ~200–210 mg Very close to oyster; values vary widely by strain (range 100–350 mg/100g DW across studies)
3 Porcini (Boletus edulis) ~180–190 mg Wild-harvested porcini can exceed this significantly; some studies report up to 530 mg/100g DW in wild specimens
4 King Oyster (Pleurotus eryngii) ~170–180 mg Highest in fresh-weight rankings per some sources; concentrates slightly less efficiently on drying than regular oyster

Important ranking context: Several industry sources (including ErgoYoung, 2025) rank King Oyster #1 on a fresh weight basis (13 mg/100g fresh) and Porcini #2 (10 mg/100g fresh), with Shiitake lower (6 mg/100g fresh). The dry-weight ranking from Tian et al. 2023 (the most comprehensive peer-reviewed study to date) shows Shiitake and Oyster essentially tied at the top. Both rankings are valid — they reflect different measurement bases and growing conditions.

Drying effect: Hot-air drying at moderate temperatures (~57°C) preserves ergothioneine well. Studies confirm oyster mushrooms retain approximately 2.2 mg/g DW (220 mg/100g DW) and shiitake approximately 1.0–2.1 mg/g DW after drying (ScienceDirect, 2023). High-heat processing can reduce levels.

Part 2: Broader Mushroom Rankings (Dry Weight)

For additional context, here is how other mushroom species compare per 100g dried weight, from Tian et al. 2023:

Rank Mushroom Approx. mg/100g DW
1 Golden Oyster (on grape marc substrate) ~1,180 mg — exceptional; substrate-dependent
2 Golden Oyster (standard cultivation) ~830 mg
3 Shiitake ~210 mg
4 Oyster (standard) ~200 mg
5 Polypore ~184 mg
6 Porcini ~181 mg
7 King Oyster ~172 mg
8 Chestnut Mushroom ~129 mg
9 Maitake (Hen of the Woods) ~113 mg
10 Enoki ~90–100 mg
11 White Button / Champignon ~2–7 mg (fresh basis); ~20–70 mg DW

The Golden Oyster on grape marc substrate is an outlier — substrate composition can increase EGT production dramatically.

Part 3: Other Good Food Sources of Ergothioneine

Mushrooms account for approximately 95% of total dietary ergothioneine intake. All other food sources contain trace-to-modest amounts by comparison. Values below are per 100g of food as commonly consumed (fresh or prepared weight unless noted).

Rank Food Approx. EGT per 100g Mechanism / Notes
1 Tempeh ~1–5 mg Fermented soy; fungi involved in fermentation produce EGT
2 Chicken liver / Beef liver ~0.5–1.5 mg Animals accumulate EGT from diet; organ meats concentrate it
3 Kidney (pork, beef) ~0.5–1.2 mg Organs that filter and accumulate EGT
4 Asparagus ~0.2–0.5 mg Absorbs EGT from soil via mycorrhizal fungi (AMF)
5 Spirulina (Arthrospira platensis) ~0.3–0.5 mg One of the higher non-fungal plant-like sources
6 Black beans ~0.1–0.3 mg Absorbs EGT via arbuscular mycorrhizal fungi (AMF); AMF-grown black beans can be up to 72x richer
7 Oat bran / Whole oats ~0.1–0.2 mg Cereal grains absorb trace EGT from soil fungi
8 Garlic ~0.05–0.15 mg Trace amounts via soil absorption
9 Pork / Beef / Chicken (muscle meat) ~0.05–0.15 mg Low levels from animals consuming EGT-containing plants and fungi
10 Scallops / Oysters (shellfish) ~0.05–0.1 mg Marine organisms accumulate trace EGT
11 Fermented foods (miso, kimchi, sourdough, sauerkraut, natto) Trace (~0.01–0.05 mg) Bacteria like Methylobacterium produce minor EGT during fermentation

Summary: Key Takeaways

On the four mushrooms asked about: All four are rich sources with very similar dry-weight concentrations (~170–220 mg/100g dried). The differences between them are smaller than the variation caused by growing conditions. Oyster and Shiitake edge ahead slightly in peer-reviewed dry-weight measurements; King Oyster and Porcini rank higher in fresh-weight comparisons used by many industry sources.

On other foods: The gap between mushrooms and everything else is enormous. Even the best non-mushroom source (tempeh at ~5 mg/100g) delivers roughly 40–100 times less EGT per 100g than dried mushrooms. Consuming dried mushrooms even in small amounts (10–15g rehydrated serving) delivers far more ergothioneine than any other dietary strategy.

No official RDA exists for ergothioneine; research-backed target estimates range from ~2.25 mg/day (Nutrivore/Ballantyne) to higher amounts in supplementation trials (5–25 mg/day).

Sources:

#14

Ergothioneine (EGT): How Much Mushroom You Need for 25mg Per Day

There is no formal RDA, but clinical research trials have used 5–25mg/day as a target range. This analysis uses 25mg as the upper practical daily target — the dose used in human supplementation studies showing benefits.

A note on measurement bases: All calculations use two separate bases:

  • Dried mushroom: values in mg per 100g dry weight (DW), sourced from Tian et al. 2023 (British Journal of Nutrition) and ScienceDirect drying studies
  • Fresh mushroom: values in mg per 100g fresh (wet) weight, drawn from multiple sources with ranges noted due to genuine study variability

Part 1: Dried Mushrooms — Grams Needed to Reach 25mg EGT

Ranked lowest to highest consumption required (easiest to hardest to achieve the target):

Rank Mushroom EGT per 100g Dried Grams Dried Needed Tablespoons (approx.) Rehydrated Weight (approx.)
1 Oyster ~210 mg ~12g ~2.5 tbsp ~72–96g
2 Shiitake ~205 mg ~12g ~2.5 tbsp ~72–96g
3 Porcini ~185 mg ~14g ~3 tbsp ~84–112g
4 King Oyster ~175 mg ~14g ~3 tbsp ~84–112g

Key finding: All four mushrooms deliver 25mg EGT in just 12–14g of dried product — roughly 2–3 tablespoons. The differences between them are small. A single standard recipe portion of dried mushrooms (typically 15–30g) easily exceeds the 25mg daily target for all four types.

Rehydrated weight assumes dried mushrooms absorb 6–8x their dry weight in water when soaked.

Part 2: Fresh Mushrooms — Grams Needed to Reach 25mg EGT

Because fresh EGT values vary considerably across studies (strain, substrate, growing conditions), a low and high estimate range is given. The “likely” column represents a practical midpoint.

Rank Mushroom EGT per 100g Fresh (range) Grams Fresh Needed (Low estimate) Grams Fresh Needed (High estimate) Practical Midpoint Cups Sliced (approx.)
1 Porcini(wild) 10–53 mg ~47g ~250g ~120g ~1–2 cups
2 King Oyster 13–24 mg ~104g ~192g ~140g ~1.5 cups
3 Oyster 11–20 mg ~125g ~227g ~160g ~1.5–2 cups
4 Shiitake 6–35 mg ~71g ~417g ~175g ~1.5–2.5 cups

Why such wide ranges? Growing substrate, mushroom strain, light exposure, and harvest timing all dramatically affect EGT levels. Wild-harvested porcini consistently outperforms cultivated porcini. High-EGT shiitake strains (Penn State research, Kalaras et al. 2017) produce up to 35mg/100g fresh; standard commercial shiitake averages closer to 6–13mg/100g.

Practical takeaway for fresh mushrooms: A generous serving of any of these four (roughly 120–200g, about 1–2 cups sliced) provides approximately 25mg EGT, though this is less guaranteed than with dried mushrooms due to variability in cultivation.

Part 3: Broader Mushroom Ranking (Dried) — Grams for 25mg EGT

Including other mushroom species for full context:

Rank Mushroom EGT per 100g Dried Grams Dried Needed Notes
1 Golden Oyster (specialty substrate) ~1,180 mg ~2g Exceptional outlier; substrate-dependent
2 Golden Oyster (standard) ~830 mg ~3g
3 Oyster ~210 mg ~12g
4 Shiitake ~205 mg ~12g
5 Polypore ~184 mg ~14g
6 Porcini ~185 mg ~14g
7 King Oyster ~175 mg ~14g
8 Chestnut Mushroom ~129 mg ~19g
9 Maitake (Hen of the Woods) ~113 mg ~22g
10 Enoki ~95 mg ~26g
11 White Button / Champignon ~20–70 mg ~36–125g Wide range; lowest EGT density

Practical Summary Table

Form Oyster Shiitake Porcini King Oyster
Dried needed for 25mg EGT 12g (~2.5 tbsp) 12g (~2.5 tbsp) 14g (~3 tbsp) 14g (~3 tbsp)
Fresh needed for 25mg EGT 125–227g (~1.5–2 cups) 71–417g (~1–4 cups) 47–250g (~0.5–2 cups) 104–192g (~1–1.5 cups)
EGT per 100g dried ~210 mg ~205 mg ~185 mg ~175 mg
EGT per 100g fresh (range) 11–20 mg 6–35 mg 10–53 mg 13–24 mg

Bottom line: All four mushrooms are remarkably efficient EGT sources in dried form. A 12–14g serving of dried mushrooms — easily incorporated into a soup, sauce, or stir-fry — is all that is needed to reach the 25mg daily target. For fresh mushrooms, a single generous serving (~150–200g) is sufficient across all four types at mid-range EGT values.

3 Likes
#15

Thank you for the excellent information!

Just one note on the EGT content of spirulina - the value reported in the table above seems far too low. The most definite study on the EGT content of cyanobacteria(1) found between 0.2 and 0.6 mg/g DW for different spirulina preparations. Even if the stated values are FW (although I would assume nobody consumes spirulina that way) they are still off by an order of magnitude.

I think that makes spirulina a very interesting source of EGT, particulary given the fact that it also contains high levels another promising anti aging molecule: phycocyanin, a highly potent inhibitor of NADPH oxidase - in fact, it is the only dietary source of that molecule.

  1. Pfeiffer C, Bauer T, Surek B, Schömig E, and Gründemann D. Cyanobacteria produce high levels of ergothioneine. Food Chem 129: 1766–1769, 2011

https://www.sciencedirect.com/science/article/abs/pii/S0308814611009344?via%3Dihub

1 Like
#16

Thanks, good information. Of course the issue with all these supplies (mushrooms or spiralina) is that there is a wide variation in the levels of ergothioneine and nobody tests or validates. I’m starting to think that supplements (at least periodically) is the best approach to make sure you’re getting the levels you want.

pfeiffer2011.pdf (339.4 KB)